首页> 外文会议>Latin American Meeting on Optics, Lasers, and Their Applications >New Treatment Applying Low Level Laser Therapy for Acute Dehiscence Saphenectomy in Post Myocardial Revascularization
【24h】

New Treatment Applying Low Level Laser Therapy for Acute Dehiscence Saphenectomy in Post Myocardial Revascularization

机译:低水平激光治疗急性开裂术后急性脱毛术后血管内切除术的新治疗

获取原文

摘要

Introduction: In Brazil, the main cause of death is the coronary heart disease and the surgical treatment applied in such cases is the Myocardial Revascularization (MR). Patients undergoing to MR through saphenous vein bypass development dehiscence in 10% of the cases. Dehiscence of surgical incision through Biomodulation treatment with Low Level Laser Therapy (LLLT) in patients who underwent to MR seems to be an unprecedented new therapy and a less invasive technique, which can benefit patients and Institutions, reducing costs. Methodology: It was analyzed 7 diabetic patients, mean age 51, 8 years old that post MR surgery presented dehiscence of the saphenectomy incision on lower limb with erithema, edema and pain. The wounds area varies from 2,2 until 34,8 cm and deep from 0,1 until 1,1 cm. It was used only Diode Laser C.W. (655 nm wavelength), Power = 25 mW, Time = 30 s, Fluence = 4 J/cm2 applied punctually around surgical wound's sore, by 2 cm distance. Results: It was observed granulated tissue all around the incision, as well as decreased inflammatory process, reduction fibrin and wound's size, besides analgesic effect since the first application. It was required in superficial wounds only 3 applications, while in the extensive wounds 8–10 applications were necessary. The LLLT has shown a remarkable role as a wound healing facilitated agent, reflecting the reduction of inflammatory process and improving analgesia. Conclusion: LLLT assisted dehiscence post saphenectomy showed a substantial improvement to the patient's quality of life, with a cost-effectiveness treatment that can benefit both patients and Institutions as an effective and less invasive therapy.
机译:介绍:在巴西,死亡原因是冠心病,在这种情况下应用的手术治疗是心肌血运重建(MR)。患者通过隐静脉旁路发育在10%的案件中的发布开裂。通过较低的患者的生物调制治疗(LLLT)对先生的患者进行了缺陷,似乎是前所未有的新治疗和较少的侵入性技术,可以使患者和机构受益,降低成本。方法论:分析了7名糖尿病患者,平均51岁,8岁,前后手术前呈现出在肢体,水肿和疼痛的下肢上的Saphenectomy切口的裂开。伤口区域从2,2,8厘米不同,从0.1厘米深度变化。它仅用于二极管激光器C.W.(655nm波长),功率= 25mW,时间= 30秒,注重手术伤口疼痛的注重效应= 4J / cm2,距离2cm。结果:由于镇痛作用,观察到切口周围的粒状组织,以及减少炎症过程,减少纤维蛋白和伤口的尺寸,除了第一次应用。它是在肤浅的伤口中只需要3个应用,而在广泛的伤口中需要8-10个应用。 LLLT表现出显着的作用作为伤口愈合促进剂,反映了炎症过程的减少和改善镇痛。结论:LLLT辅助裂开术后Saphenectomy对患者的生活质量显着提高,具有成本效益的治疗,可以使患者和机构有益于有效和更少的侵入性治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号